Project Grant R21AG100775
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a Project Grant of $634,658 to The Regents of the University of Colorado (University of Colorado-Denver) on February 15, 2026, under the Aging Research program (CFDA 93.866). The award supports research investigating the interaction between systemic endothelial glycocalyx fragility and brain dysfunction in aged sepsis survivors through November 30, 2030. The research project will examine how degradation of the...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded the University of Colorado-Denver $547,371 on May 1, 2026, under the Aging Research program (CFDA 93.866) to support a five-year research project extending through January 31, 2031. The project focuses on investigating telomere entanglements—persistent DNA bridges that form when replication forks stall at dysfunctional telomeres—and their impact on genome stability. The research will examine the molecular...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded $429,000 to the University of Colorado-Denver through the Aging Research program (CFDA 93.866) on January 1, 2026, to support a two-year research project concluding December 31, 2027. This Project Grant funds biomedical research investigating the role of decreased estradiol in modulating crotonylation of myofilament proteins in aged female hearts. The research addresses the mechanisms underlying estradiol-mediated...
- Federal Grant Award Summary The University of Colorado-Denver received a $156,000 Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective April 1, 2026, through March 31, 2028. This research project, titled "Gut Check: The Impact of Gut Bacteria on Physical Function in Older Adults With and Without HIV," investigates the relationship between gut microbiome composition and physical function decline in aging populations....
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded the University of South Florida $3.297 million under the Aging Research program (CFDA 93.866) for a four-year project period (September 1, 2025 – August 31, 2029) to develop novel peptidomimetic biomaterials that inhibit amyloid-beta (Aβ42) aggregation in Alzheimer's disease. The research deliverables include the rational design and characterization of structurally related analogues to a lead compound that stabilizes Aβ...
- Federal Grant Award Summary The University of Miami, through its Office of Research Administration within the School of Medicine, received a $109,652.00 Project Grant from the National Institute on Aging (Aging Research program, CFDA 93.866) effective September 5, 2026, with a one-year completion date of September 4, 2027. This award funds research investigating T cell senescence-driven immune dysfunction in aging and HIV-positive populations. The research aims to elucidate the mechanisms by...
- Federal Grant Award Summary The National Institute on Aging awarded the University of Pennsylvania a $2.8 million Project Grant under the Aging Research program (CFDA 93.866) for the five-year period from February 1, 2026, through January 31, 2031. The grant supports research on the epigenetics of aging and age-associated diseases, with particular focus on two mechanisms: chromostasis (homeostatic mechanisms that maintain dynamic chromatin stability) and the senescence-associated secretory...
- Federal Grant Award Summary The University of North Carolina at Chapel Hill received a $647,866 Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), with an award date of August 15, 2025, and a completion date of May 31, 2030. This research project investigates the epigenetic regulation of nuclear cyclic GMP-AMP synthase (cGAS) activity in aging-related inflammation. The primary deliverable is scientific research examining how histone...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded Columbia University's Health Sciences Division a Project Grant of $6.29 million under the Aging Research program (CFDA 93.866) for the period August 1, 2025 through July 31, 2029. This award supports biomedical research directed toward understanding the aging process and age-related neurodegenerative diseases. The project employs functional and multi-omics approaches to investigate how the ubiquitin-proteasome system (UPS)...
- Federal Project Grant Award Summary The National Institute on Aging awarded the University of Rochester a Project Grant of $656,829 under the Aging Research program (CFDA 93.866), effective January 1, 2026, through December 31, 2030. This award funds research investigating the selective vulnerability of the fronto-insular network (FIN)—comprising the medial prefrontal cortex and anterior insular cortex—in aging and Alzheimer's disease (AD). The project integrates in vivo structural,...
The University of Colorado-Denver received a $429,000 Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) for a two-year project period beginning May 1, 2026 and concluding April 30, 2028. The research initiative focuses on identifying and characterizing lysosome-Golgi membrane contact sites (LG-MCSs) as novel regulatory mechanisms underlying chronic inflammation in senescent cells. The project will deliver comprehensive proteomic and functional analyses to elucidate how these organellar contact sites stabilize the STING signalosome complex—a critical driver of sustained NF-κB (nuclear factor-kappa B) activation and senescence-associated secretory phenotype (SASP) expression in aged tissues. The research addresses a significant gap in understanding the molecular mechanisms that perpetuate age-related chronic, low-grade inflammation. Through advanced molecular techniques including split-TurboID proximity labeling and quantitative mass spectrometry, the research team will generate a detailed proteomic blueprint of LG-MCSs and define their functional role in maintaining persistent inflammatory signaling without inducing senescent cell death. This work has potential to inform development of senomorphic therapies that suppress SASP expression—an emerging therapeutic strategy with fewer off-target effects compared to existing senolytics. The research supports the NIA's mission to advance biomedical understanding of aging processes and identify preventive and therapeutic approaches to age-related diseases.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $429.0k | 4/30/26 |